Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings
• There is currently no pharmacological treatment approved for cannabis dependence. • The effect of the combination of THC/CBD on cannabis withdrawal and cravings was studied. • High doses of Sativex were well tolerated and reduced cannabis withdrawal. • These data constitute support for use of Sati...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Trigo, Jose M. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2016 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
9 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Statistical analysis to identify biomarkers for safety - Clark, Matthew ELSEVIER, 2018, an international journal on biomedical and psychosocial approaches, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:161 ; year:2016 ; day:1 ; month:04 ; pages:298-306 ; extent:9 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.drugalcdep.2016.02.020 |
|---|
| Katalog-ID: |
ELV019395833 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV019395833 | ||
| 003 | DE-627 | ||
| 005 | 20230623150916.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.drugalcdep.2016.02.020 |2 doi | |
| 028 | 5 | 2 | |a GBVA2016012000009.pica |
| 035 | |a (DE-627)ELV019395833 | ||
| 035 | |a (ELSEVIER)S0376-8716(16)00095-8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 15,3 |2 ssgn | ||
| 084 | |a PHARM |q DE-84 |2 fid | ||
| 084 | |a 44.38 |2 bkl | ||
| 084 | |a 44.39 |2 bkl | ||
| 100 | 1 | |a Trigo, Jose M. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings |
| 264 | 1 | |c 2016 | |
| 300 | |a 9 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a • There is currently no pharmacological treatment approved for cannabis dependence. • The effect of the combination of THC/CBD on cannabis withdrawal and cravings was studied. • High doses of Sativex were well tolerated and reduced cannabis withdrawal. • These data constitute support for use of Sativex to attenuate cannabis withdrawal. | ||
| 650 | 7 | |a Cannabis |2 Elsevier | |
| 650 | 7 | |a Withdrawal |2 Elsevier | |
| 650 | 7 | |a Clinical trials.gov ID# NCT01748799 |2 Elsevier | |
| 650 | 7 | |a Marijuana |2 Elsevier | |
| 650 | 7 | |a Cannabidiol |2 Elsevier | |
| 650 | 7 | |a THC |2 Elsevier | |
| 700 | 1 | |a Lagzdins, Dina |4 oth | |
| 700 | 1 | |a Rehm, Jürgen |4 oth | |
| 700 | 1 | |a Selby, Peter |4 oth | |
| 700 | 1 | |a Gamaleddin, Islam |4 oth | |
| 700 | 1 | |a Fischer, Benedikt |4 oth | |
| 700 | 1 | |a Barnes, Allan J. |4 oth | |
| 700 | 1 | |a Huestis, Marilyn A. |4 oth | |
| 700 | 1 | |a Le Foll, Bernard |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Clark, Matthew ELSEVIER |t Statistical analysis to identify biomarkers for safety |d 2018 |d an international journal on biomedical and psychosocial approaches |g Amsterdam [u.a.] |w (DE-627)ELV000553670 |
| 773 | 1 | 8 | |g volume:161 |g year:2016 |g day:1 |g month:04 |g pages:298-306 |g extent:9 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.drugalcdep.2016.02.020 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OPC-PHA | ||
| 936 | b | k | |a 44.38 |j Pharmakologie |q VZ |
| 936 | b | k | |a 44.39 |j Toxikologie |q VZ |
| 951 | |a AR | ||
| 952 | |d 161 |j 2016 |b 1 |c 0401 |h 298-306 |g 9 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
j m t jm jmt |
|---|---|
| matchkey_str |
trigojosemlagzdinsdinarehmjrgenselbypete:2016----:fetofxdrefirtdoaeostvxnanbs |
| hierarchy_sort_str |
2016 |
| bklnumber |
44.38 44.39 |
| publishDate |
2016 |
| allfields |
10.1016/j.drugalcdep.2016.02.020 doi GBVA2016012000009.pica (DE-627)ELV019395833 (ELSEVIER)S0376-8716(16)00095-8 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl Trigo, Jose M. verfasserin aut Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings 2016 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • There is currently no pharmacological treatment approved for cannabis dependence. • The effect of the combination of THC/CBD on cannabis withdrawal and cravings was studied. • High doses of Sativex were well tolerated and reduced cannabis withdrawal. • These data constitute support for use of Sativex to attenuate cannabis withdrawal. Cannabis Elsevier Withdrawal Elsevier Clinical trials.gov ID# NCT01748799 Elsevier Marijuana Elsevier Cannabidiol Elsevier THC Elsevier Lagzdins, Dina oth Rehm, Jürgen oth Selby, Peter oth Gamaleddin, Islam oth Fischer, Benedikt oth Barnes, Allan J. oth Huestis, Marilyn A. oth Le Foll, Bernard oth Enthalten in Elsevier Science Clark, Matthew ELSEVIER Statistical analysis to identify biomarkers for safety 2018 an international journal on biomedical and psychosocial approaches Amsterdam [u.a.] (DE-627)ELV000553670 volume:161 year:2016 day:1 month:04 pages:298-306 extent:9 https://doi.org/10.1016/j.drugalcdep.2016.02.020 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.38 Pharmakologie VZ 44.39 Toxikologie VZ AR 161 2016 1 0401 298-306 9 045F 610 |
| spelling |
10.1016/j.drugalcdep.2016.02.020 doi GBVA2016012000009.pica (DE-627)ELV019395833 (ELSEVIER)S0376-8716(16)00095-8 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl Trigo, Jose M. verfasserin aut Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings 2016 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • There is currently no pharmacological treatment approved for cannabis dependence. • The effect of the combination of THC/CBD on cannabis withdrawal and cravings was studied. • High doses of Sativex were well tolerated and reduced cannabis withdrawal. • These data constitute support for use of Sativex to attenuate cannabis withdrawal. Cannabis Elsevier Withdrawal Elsevier Clinical trials.gov ID# NCT01748799 Elsevier Marijuana Elsevier Cannabidiol Elsevier THC Elsevier Lagzdins, Dina oth Rehm, Jürgen oth Selby, Peter oth Gamaleddin, Islam oth Fischer, Benedikt oth Barnes, Allan J. oth Huestis, Marilyn A. oth Le Foll, Bernard oth Enthalten in Elsevier Science Clark, Matthew ELSEVIER Statistical analysis to identify biomarkers for safety 2018 an international journal on biomedical and psychosocial approaches Amsterdam [u.a.] (DE-627)ELV000553670 volume:161 year:2016 day:1 month:04 pages:298-306 extent:9 https://doi.org/10.1016/j.drugalcdep.2016.02.020 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.38 Pharmakologie VZ 44.39 Toxikologie VZ AR 161 2016 1 0401 298-306 9 045F 610 |
| allfields_unstemmed |
10.1016/j.drugalcdep.2016.02.020 doi GBVA2016012000009.pica (DE-627)ELV019395833 (ELSEVIER)S0376-8716(16)00095-8 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl Trigo, Jose M. verfasserin aut Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings 2016 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • There is currently no pharmacological treatment approved for cannabis dependence. • The effect of the combination of THC/CBD on cannabis withdrawal and cravings was studied. • High doses of Sativex were well tolerated and reduced cannabis withdrawal. • These data constitute support for use of Sativex to attenuate cannabis withdrawal. Cannabis Elsevier Withdrawal Elsevier Clinical trials.gov ID# NCT01748799 Elsevier Marijuana Elsevier Cannabidiol Elsevier THC Elsevier Lagzdins, Dina oth Rehm, Jürgen oth Selby, Peter oth Gamaleddin, Islam oth Fischer, Benedikt oth Barnes, Allan J. oth Huestis, Marilyn A. oth Le Foll, Bernard oth Enthalten in Elsevier Science Clark, Matthew ELSEVIER Statistical analysis to identify biomarkers for safety 2018 an international journal on biomedical and psychosocial approaches Amsterdam [u.a.] (DE-627)ELV000553670 volume:161 year:2016 day:1 month:04 pages:298-306 extent:9 https://doi.org/10.1016/j.drugalcdep.2016.02.020 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.38 Pharmakologie VZ 44.39 Toxikologie VZ AR 161 2016 1 0401 298-306 9 045F 610 |
| allfieldsGer |
10.1016/j.drugalcdep.2016.02.020 doi GBVA2016012000009.pica (DE-627)ELV019395833 (ELSEVIER)S0376-8716(16)00095-8 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl Trigo, Jose M. verfasserin aut Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings 2016 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • There is currently no pharmacological treatment approved for cannabis dependence. • The effect of the combination of THC/CBD on cannabis withdrawal and cravings was studied. • High doses of Sativex were well tolerated and reduced cannabis withdrawal. • These data constitute support for use of Sativex to attenuate cannabis withdrawal. Cannabis Elsevier Withdrawal Elsevier Clinical trials.gov ID# NCT01748799 Elsevier Marijuana Elsevier Cannabidiol Elsevier THC Elsevier Lagzdins, Dina oth Rehm, Jürgen oth Selby, Peter oth Gamaleddin, Islam oth Fischer, Benedikt oth Barnes, Allan J. oth Huestis, Marilyn A. oth Le Foll, Bernard oth Enthalten in Elsevier Science Clark, Matthew ELSEVIER Statistical analysis to identify biomarkers for safety 2018 an international journal on biomedical and psychosocial approaches Amsterdam [u.a.] (DE-627)ELV000553670 volume:161 year:2016 day:1 month:04 pages:298-306 extent:9 https://doi.org/10.1016/j.drugalcdep.2016.02.020 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.38 Pharmakologie VZ 44.39 Toxikologie VZ AR 161 2016 1 0401 298-306 9 045F 610 |
| allfieldsSound |
10.1016/j.drugalcdep.2016.02.020 doi GBVA2016012000009.pica (DE-627)ELV019395833 (ELSEVIER)S0376-8716(16)00095-8 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl Trigo, Jose M. verfasserin aut Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings 2016 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • There is currently no pharmacological treatment approved for cannabis dependence. • The effect of the combination of THC/CBD on cannabis withdrawal and cravings was studied. • High doses of Sativex were well tolerated and reduced cannabis withdrawal. • These data constitute support for use of Sativex to attenuate cannabis withdrawal. Cannabis Elsevier Withdrawal Elsevier Clinical trials.gov ID# NCT01748799 Elsevier Marijuana Elsevier Cannabidiol Elsevier THC Elsevier Lagzdins, Dina oth Rehm, Jürgen oth Selby, Peter oth Gamaleddin, Islam oth Fischer, Benedikt oth Barnes, Allan J. oth Huestis, Marilyn A. oth Le Foll, Bernard oth Enthalten in Elsevier Science Clark, Matthew ELSEVIER Statistical analysis to identify biomarkers for safety 2018 an international journal on biomedical and psychosocial approaches Amsterdam [u.a.] (DE-627)ELV000553670 volume:161 year:2016 day:1 month:04 pages:298-306 extent:9 https://doi.org/10.1016/j.drugalcdep.2016.02.020 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.38 Pharmakologie VZ 44.39 Toxikologie VZ AR 161 2016 1 0401 298-306 9 045F 610 |
| language |
English |
| source |
Enthalten in Statistical analysis to identify biomarkers for safety Amsterdam [u.a.] volume:161 year:2016 day:1 month:04 pages:298-306 extent:9 |
| sourceStr |
Enthalten in Statistical analysis to identify biomarkers for safety Amsterdam [u.a.] volume:161 year:2016 day:1 month:04 pages:298-306 extent:9 |
| format_phy_str_mv |
Article |
| bklname |
Pharmakologie Toxikologie |
| institution |
findex.gbv.de |
| topic_facet |
Cannabis Withdrawal Clinical trials.gov ID# NCT01748799 Marijuana Cannabidiol THC |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Statistical analysis to identify biomarkers for safety |
| authorswithroles_txt_mv |
Trigo, Jose M. @@aut@@ Lagzdins, Dina @@oth@@ Rehm, Jürgen @@oth@@ Selby, Peter @@oth@@ Gamaleddin, Islam @@oth@@ Fischer, Benedikt @@oth@@ Barnes, Allan J. @@oth@@ Huestis, Marilyn A. @@oth@@ Le Foll, Bernard @@oth@@ |
| publishDateDaySort_date |
2016-01-01T00:00:00Z |
| hierarchy_top_id |
ELV000553670 |
| dewey-sort |
3610 |
| id |
ELV019395833 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV019395833</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623150916.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.drugalcdep.2016.02.020</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016012000009.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV019395833</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0376-8716(16)00095-8</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">15,3</subfield><subfield code="2">ssgn</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">PHARM</subfield><subfield code="q">DE-84</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.38</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.39</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Trigo, Jose M.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• There is currently no pharmacological treatment approved for cannabis dependence. • The effect of the combination of THC/CBD on cannabis withdrawal and cravings was studied. • High doses of Sativex were well tolerated and reduced cannabis withdrawal. • These data constitute support for use of Sativex to attenuate cannabis withdrawal.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cannabis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Withdrawal</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Clinical trials.gov ID# NCT01748799</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Marijuana</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cannabidiol</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">THC</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lagzdins, Dina</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rehm, Jürgen</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Selby, Peter</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gamaleddin, Islam</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fischer, Benedikt</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Barnes, Allan J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Huestis, Marilyn A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Le Foll, Bernard</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Clark, Matthew ELSEVIER</subfield><subfield code="t">Statistical analysis to identify biomarkers for safety</subfield><subfield code="d">2018</subfield><subfield code="d">an international journal on biomedical and psychosocial approaches</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000553670</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:161</subfield><subfield code="g">year:2016</subfield><subfield code="g">day:1</subfield><subfield code="g">month:04</subfield><subfield code="g">pages:298-306</subfield><subfield code="g">extent:9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.drugalcdep.2016.02.020</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-PHARM</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.38</subfield><subfield code="j">Pharmakologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.39</subfield><subfield code="j">Toxikologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">161</subfield><subfield code="j">2016</subfield><subfield code="b">1</subfield><subfield code="c">0401</subfield><subfield code="h">298-306</subfield><subfield code="g">9</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Trigo, Jose M. |
| spellingShingle |
Trigo, Jose M. ddc 610 ssgn 15,3 fid PHARM bkl 44.38 bkl 44.39 Elsevier Cannabis Elsevier Withdrawal Elsevier Clinical trials.gov ID# NCT01748799 Elsevier Marijuana Elsevier Cannabidiol Elsevier THC Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings |
| authorStr |
Trigo, Jose M. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV000553670 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings Cannabis Elsevier Withdrawal Elsevier Clinical trials.gov ID# NCT01748799 Elsevier Marijuana Elsevier Cannabidiol Elsevier THC Elsevier |
| topic |
ddc 610 ssgn 15,3 fid PHARM bkl 44.38 bkl 44.39 Elsevier Cannabis Elsevier Withdrawal Elsevier Clinical trials.gov ID# NCT01748799 Elsevier Marijuana Elsevier Cannabidiol Elsevier THC |
| topic_unstemmed |
ddc 610 ssgn 15,3 fid PHARM bkl 44.38 bkl 44.39 Elsevier Cannabis Elsevier Withdrawal Elsevier Clinical trials.gov ID# NCT01748799 Elsevier Marijuana Elsevier Cannabidiol Elsevier THC |
| topic_browse |
ddc 610 ssgn 15,3 fid PHARM bkl 44.38 bkl 44.39 Elsevier Cannabis Elsevier Withdrawal Elsevier Clinical trials.gov ID# NCT01748799 Elsevier Marijuana Elsevier Cannabidiol Elsevier THC |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
d l dl j r jr p s ps i g ig b f bf a j b aj ajb m a h ma mah f b l fb fbl |
| hierarchy_parent_title |
Statistical analysis to identify biomarkers for safety |
| hierarchy_parent_id |
ELV000553670 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
Statistical analysis to identify biomarkers for safety |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV000553670 |
| title |
Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings |
| ctrlnum |
(DE-627)ELV019395833 (ELSEVIER)S0376-8716(16)00095-8 |
| title_full |
Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings |
| author_sort |
Trigo, Jose M. |
| journal |
Statistical analysis to identify biomarkers for safety |
| journalStr |
Statistical analysis to identify biomarkers for safety |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2016 |
| contenttype_str_mv |
zzz |
| container_start_page |
298 |
| author_browse |
Trigo, Jose M. |
| container_volume |
161 |
| physical |
9 |
| class |
610 610 DE-600 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Trigo, Jose M. |
| doi_str_mv |
10.1016/j.drugalcdep.2016.02.020 |
| dewey-full |
610 |
| title_sort |
effects of fixed or self-titrated dosages of sativex on cannabis withdrawal and cravings |
| title_auth |
Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings |
| abstract |
• There is currently no pharmacological treatment approved for cannabis dependence. • The effect of the combination of THC/CBD on cannabis withdrawal and cravings was studied. • High doses of Sativex were well tolerated and reduced cannabis withdrawal. • These data constitute support for use of Sativex to attenuate cannabis withdrawal. |
| abstractGer |
• There is currently no pharmacological treatment approved for cannabis dependence. • The effect of the combination of THC/CBD on cannabis withdrawal and cravings was studied. • High doses of Sativex were well tolerated and reduced cannabis withdrawal. • These data constitute support for use of Sativex to attenuate cannabis withdrawal. |
| abstract_unstemmed |
• There is currently no pharmacological treatment approved for cannabis dependence. • The effect of the combination of THC/CBD on cannabis withdrawal and cravings was studied. • High doses of Sativex were well tolerated and reduced cannabis withdrawal. • These data constitute support for use of Sativex to attenuate cannabis withdrawal. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA |
| title_short |
Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings |
| url |
https://doi.org/10.1016/j.drugalcdep.2016.02.020 |
| remote_bool |
true |
| author2 |
Lagzdins, Dina Rehm, Jürgen Selby, Peter Gamaleddin, Islam Fischer, Benedikt Barnes, Allan J. Huestis, Marilyn A. Le Foll, Bernard |
| author2Str |
Lagzdins, Dina Rehm, Jürgen Selby, Peter Gamaleddin, Islam Fischer, Benedikt Barnes, Allan J. Huestis, Marilyn A. Le Foll, Bernard |
| ppnlink |
ELV000553670 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.drugalcdep.2016.02.020 |
| up_date |
2024-07-06T21:20:33.021Z |
| _version_ |
1803866166286876672 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV019395833</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623150916.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.drugalcdep.2016.02.020</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016012000009.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV019395833</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0376-8716(16)00095-8</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">15,3</subfield><subfield code="2">ssgn</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">PHARM</subfield><subfield code="q">DE-84</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.38</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.39</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Trigo, Jose M.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• There is currently no pharmacological treatment approved for cannabis dependence. • The effect of the combination of THC/CBD on cannabis withdrawal and cravings was studied. • High doses of Sativex were well tolerated and reduced cannabis withdrawal. • These data constitute support for use of Sativex to attenuate cannabis withdrawal.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cannabis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Withdrawal</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Clinical trials.gov ID# NCT01748799</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Marijuana</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cannabidiol</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">THC</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lagzdins, Dina</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rehm, Jürgen</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Selby, Peter</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gamaleddin, Islam</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fischer, Benedikt</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Barnes, Allan J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Huestis, Marilyn A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Le Foll, Bernard</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Clark, Matthew ELSEVIER</subfield><subfield code="t">Statistical analysis to identify biomarkers for safety</subfield><subfield code="d">2018</subfield><subfield code="d">an international journal on biomedical and psychosocial approaches</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000553670</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:161</subfield><subfield code="g">year:2016</subfield><subfield code="g">day:1</subfield><subfield code="g">month:04</subfield><subfield code="g">pages:298-306</subfield><subfield code="g">extent:9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.drugalcdep.2016.02.020</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-PHARM</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.38</subfield><subfield code="j">Pharmakologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.39</subfield><subfield code="j">Toxikologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">161</subfield><subfield code="j">2016</subfield><subfield code="b">1</subfield><subfield code="c">0401</subfield><subfield code="h">298-306</subfield><subfield code="g">9</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.4005775 |